Target Healthcare REIT Reports Strong Half-Year Results with Growth in Earnings and Portfolio Valuation

Story Highlights
  • Target Healthcare REIT specializes in modern care homes, focusing on high-quality tenants.
  • The company reported a 1.8% increase in EPRA NTA and a 4.5% total return for the half-year.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Target Healthcare REIT Reports Strong Half-Year Results with Growth in Earnings and Portfolio Valuation

An update from Target Healthcare REIT ( (GB:THRL) ) is now available.

Target Healthcare REIT plc reported a strong performance for the six months ending December 2024, with a 1.8% increase in EPRA NTA per share and a 4.5% total accounting return. The company has maintained a robust balance sheet with long-term fixed-rate debt and a fully covered growing dividend. The portfolio’s market valuation rose by 1.8%, driven by rental uplifts and capital expenditure, while maintaining a high occupancy rate and strong rent collection. The company benefits from sectoral tailwinds such as an aging population and a trend towards quality care homes, positioning it well for future growth.

More about Target Healthcare REIT

Target Healthcare REIT plc is a UK-listed Real Estate Investment Trust specializing in modern, purpose-built care homes. The company invests in high-quality care facilities, focusing on tenants with strong operational capabilities and a commitment to care excellence. The portfolio consists of 94 assets valued at £924.7 million, leased to 34 tenants, and aims to provide shareholders with attractive income levels alongside potential capital growth.

YTD Price Performance: 10.10%

Average Trading Volume: 1,276,114

Technical Sentiment Consensus Rating: Sell

For a thorough assessment of THRL stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App